• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    ABVC BioPharma, Inc. - Common Stock (NQ:ABVC)

    3.270 +0.030 (+0.93%)
    Streaming Delayed Price Updated: 1:05 PM EDT, Oct 9, 2025 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 48,615
    Open 3.230
    Bid (Size) 3.260 (9)
    Ask (Size) 3.270 (8)
    Prev. Close 3.240
    Today's Range 3.160 - 3.284
    52wk Range 0.4000 - 5.480
    Shares Outstanding 23,541,824
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    ABVC BioPharma Has Received a Cumulative Total of US$566,000 Under ForSeeCon Licensing Agreement Supporting GMP Facility in Hsinchu for Vitargus(R) Production
    Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
    Via NewMediaWire
    ABVC BioPharma Has Received a Cumulative Total of US$566,000 Under ForSeeCon Licensing Agreement Supporting GMP Facility in Hsinchu for Vitargus(R) Production
    Via TheNewswire.com

    Performance

    YTD
    +409.9%
    +409.9%
    1 Month
    +20.2%
    +20.2%
    3 Month
    -30.1%
    -30.1%
    6 Month
    +233.7%
    +233.7%
    1 Year
    +472.7%
    +472.7%

    More News

    Read More
    ABVC BioPharma Reports US$1.03 Million in Total Licensing Revenues Collected in Q3 to Date, Highlighting High-Margin Business Model
    Via TheNewswire.com
    ABVC BioPharma Reports US$1.03 Million in Total Licensing Revenues Collected in Q3 to Date, Highlighting High-Margin Business Model
    Via NewMediaWire
    BioKey Stands as a Strategic U.S. Pharmaceutical Platform Amid Global Tariff Shifts
    Via TheNewswire.com
    Topics World Trade
    ABVC BioPharma Strengthens Oncology Partnership With $100,000 Milestone Payment From OncoX BioPharma
    Via TheNewswire.com
    ABVC BioPharma Receives $450,000 in Licensing Payments From OncoX BioPharma in Q3 2025
    Via NewMediaWire
    ABVC BioPharma Receives $450,000 in Licensing Payments From OncoX BioPharma in Q3 2025
    Via TheNewswire.com
    BioLite, Inc., an ABVC BioPharma Subsidiary, Receives $230,000 Milestone Payment from AiBtl, Advancing Botanical Drug Licensing Collaboration
    Via NewMediaWire
    BioLite, Inc., an ABVC BioPharma Subsidiary, Receives $230,000 Milestone Payment from AiBtl, Advancing Botanical Drug Licensing Collaboration
    Via TheNewswire.com
    ABVC BioPharma Records $100,000 Licensing Milestone From ForSeeCon, Strengthening Eye Health Program
    Via TheNewswire.com
    ABVC BioPharma Receives $150K Milestone From AiBtl, Bringing Total Licensing Revenue to $846K Across Strategic Partnerships
    Via TheNewswire.com
    ABVC BioPharma Receives $100,000 Milestone Payment From ForSeeCon, Strengthening Vitargus(R) Licensing Deal
    Via TheNewswire.com
    ABVC BioPharma Receives $100,000 Milestone Payment From ForSeeCon, Strengthening Vitargus(R) Licensing Deal
    Via NewMediaWire
    ABVC BioPharma, Inc. Reports 103% Year-Over-Year Asset Growth and Secures $350K in Post-Quarter Licensing Revenue in Q2 2025
    Via NewMediaWire
    ABVC BioPharma, Inc. Reports 103% Year-Over-Year Asset Growth and Secures $350K in Post-Quarter Licensing Revenue in Q2 2025
    Via TheNewswire.com
    Abvc BioPharma Doubles Assets in Q2
    Via The Motley Fool
    BioKey Stands as a Strategic U.S. Pharmaceutical Platform Amid Global Tariff Shifts
    Via NewMediaWire
    Topics World Trade
    ABVC BioPharma Gains Confidence From International Investors to Support Growth Path
    Via NewMediaWire
    ABVC BioPharma Gains Confidence From International Investors to Support Growth Path
    Via TheNewswire.com
    OncoX Deepens ABVC Alliance
    Via NewMediaWire
    Topics Initial Public Offering
    OncoX Deepens ABVC Alliance
    Via TheNewswire.com
    Topics Initial Public Offering
    ABVC BioPharma Strengthens Oncology Partnership With $100,000 Milestone Payment From OncoX BioPharma
    Via NewMediaWire
    ABVC BioPharma Records $100,000 Licensing Milestone From ForSeeCon, Strengthening Eye Health Program
    Via NewMediaWire
    ABVC BioPharma Receives $150K Milestone From AiBtl, Bringing Total Licensing Revenue to $846K Across Strategic Partnerships
    Via NewMediaWire

    Frequently Asked Questions

    Is ABVC BioPharma, Inc. - Common Stock publicly traded?
    Yes, ABVC BioPharma, Inc. - Common Stock is publicly traded.
    What exchange does ABVC BioPharma, Inc. - Common Stock trade on?
    ABVC BioPharma, Inc. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for ABVC BioPharma, Inc. - Common Stock?
    The ticker symbol for ABVC BioPharma, Inc. - Common Stock is ABVC on the Nasdaq Stock Market
    What is the current price of ABVC BioPharma, Inc. - Common Stock?
    The current price of ABVC BioPharma, Inc. - Common Stock is 3.270
    When was ABVC BioPharma, Inc. - Common Stock last traded?
    The last trade of ABVC BioPharma, Inc. - Common Stock was at 10/09/25 01:05 PM ET
    What is the market capitalization of ABVC BioPharma, Inc. - Common Stock?
    The market capitalization of ABVC BioPharma, Inc. - Common Stock is 76.98M
    How many shares of ABVC BioPharma, Inc. - Common Stock are outstanding?
    ABVC BioPharma, Inc. - Common Stock has 77M shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms Of Service.